Skip to main content
SpringerLink
Log in

Continuous versus Intermittent Neuroleptic Therapy in Schizophrenia

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., American Psychiatric Association, Washington, D.C., 1980

    Google Scholar 

  • Carpenter WT, Hanlon TE, Heinrichs DW, Summerfeldt AT, Kirkpatrick B, et al. Continuous versus targeted medication in schizophrenic outpatients; outcome results. American Journal of Psychiatry 147: 1138–1148, 1990

    PubMed  Google Scholar 

  • Carpenter WT, Heinrichs DW, Hanlon TE. A comparative trial of pharmacologic strategies in schizophrenia. American Journal of Psychiatry 144: 1466–1470, 1987

    PubMed  Google Scholar 

  • Carpenter WT, Stephens J, Rey A, Hanlon TE, Heinrichs DW. Early intervention versus continuous pharmacotherapy in schizophrenia. Psychopharmacology Bulletin 18: 21–23, 1982

    Google Scholar 

  • Docherty JP, Van Kammen DP, Siris SG, Marder SR. Stages of onset of schizophrenic psychosis. American Journal of Psychiatry 135: 420–427, 1978

    CAS  PubMed  Google Scholar 

  • Endicott J, Spitzer RL, Fleiss J, Cohen J. The global assessment scale; a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33: 766–771, 1976

    Article  CAS  PubMed  Google Scholar 

  • Falloon I, Watt DC, Shepherd M. The social outcome of patients in a trial of long term continuation therapy in schizophrenia; pimozide versus fluphenazine. Psychological Medicine 8: 265–274, 1978

    Article  CAS  PubMed  Google Scholar 

  • Guy W. ECDEU Assessment Manual for Psychopharmacology, National Institute of Mental Health Psychopharmacology Research Branch, Rockville, 1976

    Google Scholar 

  • Herz MI, Glazer W, Mirza MA, Mostert M, Hafez H. Treating prodromal episodes to prevent relapse in schizophrenia. In Boker & Brenner (Eds) Schizophrenia as a systems disorder (British Journal of Psychiatry Suppl. No. 5), Royal College of Psychiatrists, London, 1989

    Google Scholar 

  • Herz MI, Glazer WM, Mostert MA, Sheard MA, Szymanski HV, et al. Intermittent versus maintenance treatment in schizophrenia: two year results. Archives of General Psychiatry 48: 333–339, 1991

    Article  CAS  PubMed  Google Scholar 

  • Herz MI, Melville C. Relapse in schizophrenia. American Journal of Psychiatry 137: 801–805, 1980

    CAS  PubMed  Google Scholar 

  • Herz MI, Szymanski HV, Simon J. Intermittent treatment for stable schizophrenic outpatients; an alternative to maintenance medication. American Journal of Psychiatry 139: 918–922, 1982

    CAS  PubMed  Google Scholar 

  • Hirsch SR. Clinical treatment of schizophrenia. In Bradley & Hirsch (Eds) The psychopharmacology and treatment of schizophrenia, Oxford University Press, Oxford, 1986

    Google Scholar 

  • Hirsch SR, Jolley AG, Manchanda R, McRink A. Early intervention medication as an alternative to continuous depot treatment in schizophrenia; preliminary report. In Strauss et al. (Eds) Psychosocial treatment of schizophrenia, Hans Huber, Berne, 1987

    Google Scholar 

  • Jeste DV, Potkin SG, Sinha S, Feder S, Wyatt RJ. Tardive dyskinesia; reversible and persistent. Archives of General Psychiatry 36: 585–590, 1979

    Article  CAS  PubMed  Google Scholar 

  • Jolley AG, Hirsch SR, McRink A, Manchanda R. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients; clinical outcome at one year. British Medical Journal 298: 985–990, 1989

    Article  CAS  PubMed  Google Scholar 

  • Jolley AG, Hirsch SR, Morrison E, McRink A, Wilson L. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients; clinical and social outcome at two years. British Medical Journal 301: 837–842, 1990

    Article  CAS  PubMed  Google Scholar 

  • Johnson DAW. Studies of depressive symptoms in schizophrenia. British Journal of Psychiatry 139: 89–101, 1981

    Article  CAS  PubMed  Google Scholar 

  • Johnson DAW, Ludlow JM, Street K, Taylor RDW. The discontinuance of maintenance neuroleptic therapy; drug and social consequences. Acta Psychiatrica Scandinavica 67: 339–352, 1983

    Article  CAS  PubMed  Google Scholar 

  • Kane JM, Rifkin A, Woerner M, Sarantakos S. Dose response relationships in maintenance drug treatment for schizophrenia. Psychopharmacology Bulletin 6: 205–235, 1986

    Google Scholar 

  • Kane J, Honigfeld G, Singer J, Meltzer HY and the Clozaril Collaborative Study Group. Clozapine for the treatment resistant schizophrenic. Archives of General Psychiatry 45: 789–796, 1988

    Article  CAS  PubMed  Google Scholar 

  • Kane JM, Rifkin A, Woerner M, Sarantakos S. Dose response relationships in maintenance drug treatment for schizophrenia. Psychopharmacology Bulletin 6: 205–235, 1986

    Google Scholar 

  • Levine J, Carpenter WT, Kirkpatrick B, Summerfelt A, Hanlon T. Targeted medication dosing and tardive dyskinesia. Paper presented at the New Clinical Drug Evaluation Meeting, Key Biscayne, Florida, May, 1990

  • Pietzcker A. A German multicentre study of the neuroleptic long term therapy of schizophrenic patients. Pharmacopsychiatry 19: 161–166, 1985

    Article  Google Scholar 

  • Schooler NR. Maintenance medication for schizophrenia; strategies for dose reduction. Schizophrenia Bulletin 17: 311–324, 1991

    CAS  PubMed  Google Scholar 

  • Smith JM, Kucharski LT, Eblen C, Knutson E, Linn C. An assessment of tardive dyskinesia in schizophrenic outpatients. Pharmacologia, Berlin 64: 90–104, 1979

    Google Scholar 

  • Spitzer RL, Endicott J. An integrated group of forms for automated psychiatric case records; a progress report. Archives of General Psychiatry 24: 448–453, 1971

    Article  CAS  PubMed  Google Scholar 

  • Spitzer RL, Endicott J. Schedule for affective disorders and schizophrenia; lifetime version, Biometrics Division, New York State Psychiatric Institute, New York, 1975

    Google Scholar 

  • Van Putten T, Marder SR. The dysphoria syndrome and its relation to EPS. In Pichot et al. (Eds) Psychiatry: the state of the art, Vol. 1, pp. 595–601, Planus Press, New York, 1985

    Google Scholar 

  • Van Putten T, May PRA. ‘Akinetic depression’ in schizophrenia. Archives of General Psychiatry 35: 1101–1106, 1978

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Charing Cross Hospital, London, W6 8RF, England

    Anthony G. Jolley & Steven R. Hirsch

  2. Charing Cross and Westminster Medical School, London, England

    Anthony G. Jolley & Steven R. Hirsch

Authors
  1. Anthony G. Jolley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven R. Hirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jolley, A.G., Hirsch, S.R. Continuous versus Intermittent Neuroleptic Therapy in Schizophrenia. Drug-Safety 8, 331–339 (1993). https://doi.org/10.2165/00002018-199308050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199308050-00001

Keywords

Search

Navigation